Breaking News: Indian COVAXIN effective against ALPHA and DELTA variants of the Wuhan Virus

 Here is a short version of what you will read in the link below:

"The US National Institute of Health has said Covaxin “effectively neutralizes” both Alpha (B.1.1.7) and Delta (B1.617) variants of the coronavirus disease (Covid-19) in what is a major endorsement of the anti-Covid vaccine developed by India’s Bharat Biotech International Limited."

https://www.hindustantimes.com/india-news/covaxin-effectively-neutralises-alpha-delta-covid-19-variants-says-us-national-institute-of-health-101625013670164-amp.html

 Original Virus:     Possible origin Wuhan, China
Alpha variant:       First showed up in the UK
Delta Variant:        First showed up in India

Lamda Variant:     First appeared in Peru


 Note:

Here is a link to the NIH information:

Adjuvant Developed with NIH Funding Enhances Efficacy of India’s COVID-19 Vaccine | NIH: National Institute of Allergy and Infectious Diseases



Bharath Biotech collaborated with Virovax LLC of the USA headed by IISC researcher.
ViroVax, LLC (virovaxllc.com)